We cannot exclude that additional molecular mechanisms/pathways downstream to SOX6, independent from LIN28B downregulation concur to the observed tumor suppressive outcome and it is also likely that reduction of LIN28B expression does not exclusively impact the Let-7 axis. The gene discussed is LIN28B; the disease is neoplasm.